Stockscreener 앱 받기
1.56
1.30%
0.02
시간 외 거래:
1.52
-0.04
-2.56%
Pulmatrix Inc 주식(PULM)의 최신 뉴스
Precision Trading with Pulmatrix Inc. (PULM) Risk Zones - Stock Traders Daily
Pulmatrix Inc (NASDAQ: PULM) Share Price, PULM Stock News, PULM Share Price & Updates - Kalkine
Form 8K Pulmatrix Inc For: 13 August By Investing.com - Investing.com Australia
Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger - Morningstar
Pulmatrix Announces Second Quarter 2026 Financial Results And Progress On Merger - TradingView
Pulmatrix posts Q2 2026 net loss $1.04M, cash $2.2M; files Form S-4 for Eos merger - TradingView
Pulmatrix, Inc. Q2 2026: Net loss $1.05M, EPS $(0.29) — 10-Q Summary - TradingView
PULM: Q2 2026 featured lower expenses, a narrowed net loss, and progress toward the Eos merger - TradingView
Press Release: Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger - Moomoo
Pulmatrix Inc (PULM) Stock News Today - TradingKey
Pulmatrix Inc (PULM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PULM|Pulmatrix Inc|Price:1.640|Chg%:-0.010 - TradingKey
PULM|Pulmatrix Inc|Price:1.670|Chg%:-0.060 - TradingKey
PULM|Pulmatrix Inc|Price:1.650|Chg%:-0.120 - TradingKey
Pulmatrix Inc (PULM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Pulmatrix Inc (PULM) Cash Flow - TradingKey
TradingKey - TradingKey
Pulmatrix Inc (PULM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Pulmatrix Inc (PULM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Pulmatrix Inc (PULM) Institutional Confidence - TradingKey
Pulmatrix Inc (PULM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pulmatrix, Inc. Revenue Breakdown – NASDAQ:PULM - TradingView
Pulmatrix Inc (PULM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Pulmatrix Inc. (PULM) Q2 2025 Earnings: EPS of -$0.42 Reported; Stock Climbs 4.97%Margin Compression Risk - dars.gov.et
What Just Happened to Pulmatrix (PULM) Stock - Kavout | AI
Pulmatrix Inc. (PULM) Slips 3.89% as Stock Nears Critical Support at $1.48BPI Bear Correction - dars.gov.et
Trading the Move, Not the Narrative: (PULM) Edition - Stock Traders Daily
Halper Sadeh LLC investigates fairness of recen... - Pluang
Halper Sadeh LLC is Investigating Whether SLP, HUN, OLN, PULM are Obtaining Fair Deals for their Shareholders - GlobeNewswire Inc.
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger-PULM, SLP, OLN, and HUN - The Malaysian Reserve
SHAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--PULM, SLP, OLN, and HUN - Sahm
Pulmatrix (NASDAQ: PULM) to Merge with Eos; 75.2M Shares to Be Issued - Stock Titan
PULMPulmatrix Inc Latest SEC Filings - Finviz
PULM Q2 2025 Earnings: Continued R&D Investment Drives Net Loss as Pipeline AdvancesBanking Earnings Report - dars.gov.et
Enterprise value to EBITDA forward of Pulmatrix, Inc. – NASDAQ:PULM - TradingView
Pulmatrix | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactionsmoomoo - Moomoo
Pulmatrix (PULM) Holds Near Support After Modest DeclineStop Loss Guidance - dars.gov.et
(PULM) Volatility Zones as Tactical Triggers - Stock Traders Daily
Pulmatrix Inc Actuals & Estimates (NASDAQ:PULM) - TradingView
Pulmatrix Inc Actuals & Estimates (LS:A3DWEE) - TradingView
Enterprise value to revenue forward of Pulmatrix, Inc. – NASDAQ:PULM - TradingView
Price to earnings forward of Pulmatrix, Inc. – NASDAQ:PULM - TradingView
Enterprise value to EBITDA forward of Pulmatrix Inc – TRADEGATE:2PU - TradingView
PULM Q2 2025 Earnings: Clinical‑Stage Biotech Reports Loss Per Share of $0.42, No RevenueEBITDA Estimate Trend - dars.gov.et
Price to earnings forward of Pulmatrix Inc – TRADEGATE:2PU - TradingView
Enterprise value to EBIT forward of Pulmatrix, Inc. – NASDAQ:PULM - TradingView
PULM Q2 2025 Earnings: Net Loss of $0.42 Per Share as Clinical-Stage Biotech Advances PipelineMargin Guidance - DonanımHaber
Pulmatrix Inc (PULM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Pulmatrix Inc (PULM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Pulmatrix (NASDAQ: PULM) posts 2025 loss as Cullgen merger to give Cullgen 96.4% - Stock Titan
PULM Q2 2025 Earnings: Net Loss Reported, Stock Rises as Investors Look Past Revenue AbsenceConsensus Forecast Report - newsline.com
PULM Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Pulmatrix Q2 2025 Earnings: Loss Per Share of $0.42 as Clinical Pipeline AdvancesEarnings Preview - newsline.com
Pulmatrix Q2 2025 Earnings: Net Loss of $0.42 per Share as Biotech Continues Pipeline DevelopmentReturn On Capital - newsline.com
PULM Q2 2025 Earnings: Clinical-Stage Biotech Reports EPS of -$0.42Revenue Inflection Point - newsline.com
Pulmatrix Inc. (PULM) Q2 2025 Earnings: Narrowing Losses Amid Clinical MilestonesCore Business Growth - newsline.com
1.80%
1.77%
자본화:
|
볼륨(24시간):